{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T20:20:45Z","timestamp":1771964445630,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol Phys Technol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12194-025-00898-y","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T15:01:41Z","timestamp":1742482901000},"page":"477-483","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A study of differences in absorbed dose estimates by images used in dosimetry of Lu-177-DOTATATE therapy"],"prefix":"10.1007","volume":"18","author":[{"given":"Yui","family":"Masaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoyuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4338-3497","authenticated-orcid":false,"given":"Shingo","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"6","key":"898_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.annonc.2023.03.001","volume":"34","author":"KL Pomykala","year":"2023","unstructured":"Pomykala KL, Hadaschik BA, Sartor O, et al. Next generation radiotheranostics promoting precision medicine. Ann Oncol. 2023;34(6):507\u201319. https:\/\/doi.org\/10.1016\/j.annonc.2023.03.001.","journal-title":"Ann Oncol"},{"issue":"2","key":"898_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11912-017-0567-8","volume":"19","author":"M Cives","year":"2017","unstructured":"Cives M, Strosberg J. Radionuclide therapy for neuroendocrine tumors. Curr Oncol Rep. 2017;19(2):9. https:\/\/doi.org\/10.1007\/s11912-017-0567-8.","journal-title":"Curr Oncol Rep"},{"key":"898_CR3","doi-asserted-by":"crossref","unstructured":"Waldmann CM, Stuparu AD, van Dam RM, Slavik R. The search for an alternative to [68Ga]Ga-DOTA-TATE in neuroendocrine tumor theranostics: current state of 18F-labeled somatostatin analog development. Theranostics. 2019;9(5):1336\u20131347. https:\/\/www.thno.org\/v09p1336.htm.","DOI":"10.7150\/thno.31806"},{"issue":"13","key":"898_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.941832","volume":"31","author":"PE Harris","year":"2022","unstructured":"Harris PE, Zhernosekov K. The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next? Front Endocrinol (Lausanne). 2022;31(13): 941832. https:\/\/doi.org\/10.3389\/fendo.2022.941832.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"898_CR5","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1007\/s00259-017-3678-4","volume":"44","author":"A Sundl\u00f6v","year":"2017","unstructured":"Sundl\u00f6v A, Sj\u00f6green-Gleisner K, Svensson J, et al. Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry. Eur J Nucl Med Mol Imaging. 2017;44(9):1480\u20139. https:\/\/doi.org\/10.1007\/s00259-017-3678-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"898_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12149-020-01440-3","volume":"34","author":"TI Goetz","year":"2020","unstructured":"Goetz TI, Lang EW, Prante O, et al. Three-dimensional Monte Carlo-based voxel-wise tumor dosimetry in patients with neuroendocrine tumors who underwent 177Lu-DOTATOC therapy. Ann Nucl Med. 2020;34(4):244\u201353. https:\/\/doi.org\/10.1007\/s12149-020-01440-3.","journal-title":"Ann Nucl Med"},{"issue":"1","key":"898_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","volume":"6","author":"E Garin","year":"2021","unstructured":"Garin E, Tselikas L, Guiu B, et al. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol. 2021;6(1):17\u201329. https:\/\/doi.org\/10.1016\/S2468-1253(20)30290-9.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"898_CR8","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s00259-022-05727-7","volume":"49","author":"K Sj\u00f6green Gleisner","year":"2022","unstructured":"Sj\u00f6green Gleisner K, Chouin N, Gabina PM, et al. EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands. Eur J Nucl Med Mol Imaging. 2022;49(6):1778\u2013809. https:\/\/doi.org\/10.1007\/s00259-022-05727-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 3","key":"898_CR9","doi-asserted-by":"publisher","first-page":"36S","DOI":"10.2967\/jnumed.121.262748","volume":"62","author":"C Uribe","year":"2021","unstructured":"Uribe C, Peterson A, Van B, et al. An international study of factors affecting variability of dosimetry calculations, part 1: design and early results of the SNMMI dosimetry challenge. J Nucl Med. 2021;62(Suppl 3):36S-47S. https:\/\/doi.org\/10.2967\/jnumed.121.262748.","journal-title":"J Nucl Med"},{"issue":"7","key":"898_CR10","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.2967\/jnumed.122.265094","volume":"64","author":"J Brosch-Lenz","year":"2023","unstructured":"Brosch-Lenz J, Ke S, Wang H, et al. An international study of factors affecting variability of dosimetry calculations, part 2: overall variabilities in absorbed dose. J Nucl Med. 2023;64(7):1109\u201316. https:\/\/doi.org\/10.2967\/jnumed.122.265094.","journal-title":"J Nucl Med"},{"key":"898_CR11","doi-asserted-by":"publisher","unstructured":"Willowson KP, Ryu H, Jackson P, Singh A, Eslick E, Bailey DL. A comparison of 2D and 3D kidney absorbed dose measures in patients receiving 177Lu-DOTATATE. Asia Ocean J Nucl Med Biol. 2018;6(2):113\u201319. https:\/\/doi.org\/10.22038\/aojnmb.2018.26105.1182.","DOI":"10.22038\/aojnmb.2018.26105.1182"},{"key":"898_CR12","doi-asserted-by":"publisher","unstructured":"Ljungberg M, Celler A, Konijnenberg MW, et al. MIRD pamphlet No. 26: joint EANM\/MIRD guidelines for quantitative 177Lu SPECT applied for dosimetry of radiopharmaceutical therapy. J Nucl Med. 2016;57(1):151\u201362. https:\/\/doi.org\/10.2967\/jnumed.115.159012.","DOI":"10.2967\/jnumed.115.159012"},{"key":"898_CR13","doi-asserted-by":"publisher","unstructured":"Miyaji N, Yamashita K, Yoneyama H, et al. The questionnaire survey of japanese practice and environment for targeted radionuclide therapy in 2021. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2023;79(3):262\u2013270. https:\/\/doi.org\/10.6009\/jjrt.2023-1317.","DOI":"10.6009\/jjrt.2023-1317"},{"issue":"1","key":"898_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40658-020-00326-7","volume":"7","author":"N Ukon","year":"2020","unstructured":"Ukon N, Zhao S, Washiyama K, et al. Human dosimetry of free 211At and meta-[211At]astatobenzylguanidine (211At-MABG) estimated using preclinical biodistribution from normal mice. EJNMMI Phys. 2020;7(1):58. https:\/\/doi.org\/10.1186\/s40658-020-00326-7.","journal-title":"EJNMMI Phys"},{"issue":"8","key":"898_CR15","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.2967\/jnumed.123.267293","volume":"65","author":"J Brosch-Lenz","year":"2024","unstructured":"Brosch-Lenz J, Kurkowska S, Frey E, Dewaraja YK, Sunderland J, Uribe C. An international study of factors affecting variability of dosimetry calculations, part 3: contribution from calculating absorbed dose from time-integrated activity. J Nucl Med. 2024;65(8):1166\u201372. https:\/\/doi.org\/10.2967\/jnumed.123.267293.","journal-title":"J Nucl Med"},{"issue":"2","key":"898_CR16","first-page":"37","volume":"40","author":"JA Siegel","year":"1999","unstructured":"Siegel JA, Thomas SR, Stubbs JB, et al. MIRD pamphlet No. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med. 1999;40(2):37\u201361.","journal-title":"J Nucl Med"},{"issue":"4 Suppl","key":"898_CR17","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/cncr.24796","volume":"116","author":"M Garkavij","year":"2010","unstructured":"Garkavij M, Nickel M, Sj\u00f6green-Gleisner K, et al. 177Lu-[DOTA0, Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: analysis of dosimetry with impact on future therapeutic strategy. Cancer. 2010;116(4 Suppl):1084\u201392. https:\/\/doi.org\/10.1002\/cncr.24796.","journal-title":"Cancer"},{"issue":"11","key":"898_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187570","volume":"12","author":"D Kupitz","year":"2017","unstructured":"Kupitz D, Wetz C, Wissel H, et al. Software-assisted dosimetry in peptide receptor radionuclide therapy with 177Lutetium-DOTATATE for various imaging scenarios. PLoS ONE. 2017;12(11): e0187570. https:\/\/doi.org\/10.1371\/journal.pone.0187570.","journal-title":"PLoS ONE"},{"key":"898_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1088\/2057-1976\/ac1550","volume":"7","author":"LM Carter","year":"2021","unstructured":"Carter LM, Ocampo Ramos JC, Kesner AL. Personalized dosimetry of\u00a0177Lu-DOTATATE: a comparison of organ- and voxel-level approaches using open-access images. Biomed Phys Eng Express. 2021;7:5. https:\/\/doi.org\/10.1088\/2057-1976\/ac1550.","journal-title":"Biomed Phys Eng Express."},{"issue":"3","key":"898_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12149-018-1230-7","volume":"32","author":"M Hosono","year":"2018","unstructured":"Hosono M, Ikebuchi H, Nakamura Y, et al. Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy. Ann Nucl Med. 2018;32(3):217\u201335. https:\/\/doi.org\/10.1007\/s12149-018-1230-7.","journal-title":"Ann Nucl Med"}],"container-title":["Radiological Physics and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12194-025-00898-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12194-025-00898-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12194-025-00898-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T08:02:43Z","timestamp":1748073763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12194-025-00898-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["898"],"URL":"https:\/\/doi.org\/10.1007\/s12194-025-00898-y","relation":{},"ISSN":["1865-0333","1865-0341"],"issn-type":[{"value":"1865-0333","type":"print"},{"value":"1865-0341","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was performed following the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Boards and Ethics Committees of Kyushu University Hospital and Medical Institutions (No. 23214-00). This study was approved by the institutional review board, and the requirement for written informed consent was waived because of its retrospective study design.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}